ANI Pharmaceuticals
ANIP
#5170
Rank
HK$14.12 B
Marketcap
HK$621.40
Share price
-1.48%
Change (1 day)
24.97%
Change (1 year)

EPS for ANI Pharmaceuticals (ANIP)

EPS in 2026 (TTM): HK$32.08

According to ANI Pharmaceuticals's latest financial reports the company's current EPS (TTM) is HK$32.23. In 2025 the company made an earnings per share (EPS) of HK$27.45 an increase over its 2024 EPS that were of -HK$8.78.

EPS history for ANI Pharmaceuticals from 2013 to 2026

Annual EPS

Year EPS Change
2026 (TTM)HK$32.0816.88%
2025HK$27.45-412.5%
2024-HK$8.78
2022-HK$23.84-6.46%
2021-HK$25.4972.87%
2020-HK$14.74-476%
2019HK$3.92-62.12%
2018HK$10.35
2015HK$10.51-47.66%
2014HK$20.08-142.11%
2013-HK$47.68

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Novartis
NVS
HK$55.05 70.80%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
HK$10.27-68.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Cardinal Health
CAH
HK$51.52 59.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Jazz Pharmaceuticals
JAZZ
HK$3.61-88.81%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Evoke Pharma
EVOK
-HK$19.76-161.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-HK$33.41-203.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
HK$10.74-66.67%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Royalty Pharma
RPRX
HK$14.94-53.65%๐Ÿ‡ฌ๐Ÿ‡ง UK
Lannett Company
LCI
-HK$198.25-715.09%๐Ÿ‡บ๐Ÿ‡ธ USA